[Secondary deficiencies of humoral immunity in hematology: what management?]

Rev Med Interne. 2007 Jun:28 Spec No 2:1. doi: 10.1016/s0248-8663(07)80006-3.
[Article in French]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Agammaglobulinemia* / complications
  • Agammaglobulinemia* / drug therapy
  • Evidence-Based Medicine
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage
  • Immunoglobulins, Intravenous / therapeutic use*
  • Infections / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Multiple Myeloma / mortality
  • Prognosis

Substances

  • Immunoglobulins, Intravenous